Navigation Links
Lixte Biotechnology Holdings, Inc. Awarded Grant Under Qualifying Therapeutic Discovery Project from the U. S. Government
Date:3/2/2011

EAST SETAUKET, N.Y., March 2, 2011 /PRNewswire/ -- Lixte Biotechnology Holdings (OTC: LIXT) announced today that the company has received a $244,479.25 grant under the Qualifying Therapeutic Discovery Project (QTDP).  This grant was awarded to further development and commercialization of Lixte's novel anti-cancer compound LB-100.  The QTDP program was included as part of the Patient Protection and Affordable Care Act of 2010 to encourage development of new therapies to prevent, diagnose, and treat acute and chronic diseases.  The selection process took into consideration the potential of projects to reduce long-term healthcare costs in the United States or significantly advance the goal of curing cancer over the next 30 years.  The selections were made jointly by the Department of Health and Human Services and the Treasury Department.  

"We are extremely pleased to have qualified for this grant," said Dr. John Kovach, founder and president of Lixte. "The funds will be used as part of our effort to complete pre-clinical studies and submit an IND to the FDA to bring our novel compound LB-100 to Phase I clinical trial. LB-100 represents a new type of anti-cancer drug, which we hope will improve treatments for several different types of human cancers for which more effective therapies are urgently needed."

About Lixte Biotechnology Holdings, Inc:Lixte Biotechnology Holdings, Inc. is a cancer therapeutics company. Founded as a biomarker-diagnostics company in 2005, Lixte primary focus is discovery of new chemotherapy drugs based on targeting molecular abnormalities of common human cancers critical to their survival.

Forward-Looking StatementsThis announcement contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. For example, statements regardin
'/>"/>

SOURCE Lixte Biotechnology Holdings
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100.
2. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
3. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
4. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
5. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
6. Pharma ChemOutsourcing Targets BioNJ, PA Bio, MassBio, BayBio, SoCalBio, and NY Biotechnology Association Member Companies for September 2011 Show in New Jersey
7. Reportlinker Adds Global Biotechnology Instrumentation Industry
8. NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition
9. Reportlinker Adds Global Agricultural Biotechnology Industry
10. Champions Biotechnology Awarded $1.46 million in Grants
11. Goodwin Biotechnology Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... The Indiana Medical Device Manufacturers Council and the Indiana ... Forum to state legislators. The new policy forum was ... Indianapolis and featured two panel ... and State Sen. Brandt Hershman . Legislators also ... & Development Center, which is under construction on its ...
(Date:8/31/2015)... PHOENIX , Aug. 31, 2015  DICOM ... announced today that it was recognized as a ... Radiology software.  The awards are sponsored ... and related professionals in the medical imaging industry.  ... for radiology professionals to acknowledge the contributions of ...
(Date:8/31/2015)... , Aug. 31, 2015 Pepperl+Fuchs, ... has acquired MACTek Corporation, a leading provider of ... Pepperl+Fuchs, strategy to further extend its integrated solutions ... market.    "We are pleased to ... existing portfolio," said Jim Bolin , Pepperl+Fuchs, ...
Breaking Medicine Technology:Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 3DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2
... with HALO device leads to 100% patient response ... ... Calif., May 20 BARRX Medical, Inc., a global,technology leader in ... which report a 100% eradication,rate for early esophageal cancer and pre-cancerous ...
... Technologies,Inc. (Amex: PTN ) announced today that ... study of PL-3994, a novel, long-acting natriuretic peptide,receptor ... The study is placebo-controlled and double-blinded, and will ... many as 35 subjects will be,included, with six ...
Cached Medicine Technology:Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 2Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 3Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 2Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 3
(Date:8/31/2015)... ... August 31, 2015 , ... Women’s Excellence ... , Starting September 1st they are offering pre and postnatal fitness classes ... Body, Healthy Baby." , More information can be found at 248-601-6683. , Women’s ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Bay Pines VA ... residing across southwest Florida by hiring more doctors and nurses and expanding existing facilities ... services. , In early July, Dr. Anthony Jabre was selected to lead and grow ...
(Date:8/31/2015)... ... August 31, 2015 , ... Garden State Urology is celebrating ... of a merger of five of the busiest urology practices in Morris County. ... cost-effective and higher quality care than they did individually. Their mission statement ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Dr. Paul ... “NJ Top Doc.” , At OSSMC, Dr. Kovatis treats all surgical and non-surgical disorders ... traumatic injuries to the entire musculoskeletal system, excluding the spine. , Dr. Paul Kovatis ...
(Date:8/31/2015)... Angeles, CA (PRWEB) , ... August 31, 2015 , ... ... out of the University of Sweden showed that most adolescents who underwent bariatric surgery ... on average, the 88 adolescent bariatric patients who participated in the study felt that ...
Breaking Medicine News(10 mins):Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3
... ... Lee Sponsors Senate Resolution supporting Kevin Saunders for Chairman of the President,s ... the Senate Resolution to Kevin Saunders will be held February 10 at ... KS. The resolution supporting Kevin Saunders appointment to chairman of the President,s ...
... ... of websites produced for various cities have been created by Dr. Paul ... aesthetic and appearance related services. Lists of all the possible procedures, ... esteem are listed and described in each website. A central website, ...
... are most likely to use a shade of gray to ... journal BMC Medical Research Methodology describe the development ... be used to study people,s preferred pigment in relation to ... and Gastroenterology at University Hospital South Manchester, worked with a ...
... authorities should emphasize the positive message that the ... unassisted cessation, despite the promotion of cessation drugs ... dominant messages about smoking cessation contained in most ... at quitting smoking must be pharmacologically or professionally ...
... , ... stories are physicians reading to stay informed about key developments? MedPage Today ... Stories for the Past Week will be published Every Monday and will ... of Herbal Meds Reviewed , ICU Catheter Infections ...
... Feb. 8 Since 2003, Amway has mobilized its ... lives for children in need. , Now in its seventh ... has improved the lives of an estimated 7 million children through ... impact. , Employees and distributors alike have volunteered more than ...
Cached Medicine News:Health News:Senator Janis Lee Sponsors Senate Resolution Supporting Kevin Saunders for Chairman of the President's Council on Physical Fitness & Sports 2Health News:Senator Janis Lee Sponsors Senate Resolution Supporting Kevin Saunders for Chairman of the President's Council on Physical Fitness & Sports 3Health News:Senator Janis Lee Sponsors Senate Resolution Supporting Kevin Saunders for Chairman of the President's Council on Physical Fitness & Sports 4Health News:A New Website Series Improves Appearance and Health City by City 2Health News:Depressed people feel more gray than blue 2Health News:Nicotine replacement therapy is over-promoted since most ex-smokers quit unassisted 2Health News:MedPage Today(R) 'What Your Physicians Are Reading' 2Health News:MedPage Today(R) 'What Your Physicians Are Reading' 3Health News:Amway One by One Campaign for Children Reaches 7 Million Kids 2Health News:Amway One by One Campaign for Children Reaches 7 Million Kids 3
... monitor elevates bedside glucose testing to a ... the quality of central laboratory testing. ... strip technology. Current glucose strips use ... system measures and corrects hematocrit interference as ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
... BreatheX is a wearable CPAP (Continuous Positive ... sleep apnea. The lightweight BreatheX CPAP device ... with its built-in, rechargeable battery, and is ... no longer need to be "plugged in ...
Paraffin Block Storage System...
Medicine Products: